Mike Hennessy Jr.

AI could provide solutions to critical manufacturing inefficiencies.

Spring has returned, and with it comes INTERPHEX.

Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.

Reducing US dependency on overseas pharma manufacturing may prove critical in navigating supply chain disruptions.

Busy is good for business.